Stocks and Investing Stocks and Investing
Tue, October 18, 2022

Silvan Tuerkcan Initiated (BNTC) at Buy and Held Target at $68 on, Oct 18th, 2022


Published on 2024-10-27 23:26:14 - WOPRAI, Silvan Tuerkcan
  Print publication without navigation


Silvan Tuerkcan of JMP Securities, Initiated "Benitec Biopharma Inc." (BNTC) at Buy and Held Target at $68 on, Oct 18th, 2022.

Silvan has made no other calls on BNTC in the last 4 months.



There is 1 other peer that has a rating on BNTC. Out of the 1 peers that are also analyzing BNTC, 0 agree with Silvan's Rating of Hold.



This is the rating of the analyst that currently disagrees with Silvan


  • Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $68 on, Friday, September 23rd, 2022

Contributing Sources